BioNTech SE
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell BioNTech SE and other ETFs, options, and stocks.About BNTX
BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators.
CEOUgur Sahin
CEOUgur Sahin
Employees7,807
Employees7,807
HeadquartersMainz, Rheinland-Pfalz
HeadquartersMainz, Rheinland-Pfalz
Founded2008
Founded2008
Employees7,807
Employees7,807
BNTX Key Statistics
Market cap22.48B
Market cap22.48B
Price-Earnings ratio-17.09
Price-Earnings ratio-17.09
Dividend yield—
Dividend yield—
Average volume965.23K
Average volume965.23K
High today$90.74
High today$90.74
Low today$88.76
Low today$88.76
Open price$89.66
Open price$89.66
Volume618.10K
Volume618.10K
52 Week high$124.00
52 Week high$124.00
52 Week low$79.52
52 Week low$79.52
BNTX News
Simply Wall St 5d
How New Lung Cancer Trial Data At BioNTech Has Changed Its Investment StoryIn late March 2026, BioNTech SE presented updated clinical data from its diversified lung cancer portfolio at the European Lung Cancer Congress in Copenhagen, h...
TipRanks 6d
BioNTech’s Mpox Vaccine Study Reaches Completion: What Investors Should Watch NextBiontech Se Sponsored Adr (BNTX) announced an update on their ongoing clinical study. The study “A Randomized, Partially Observer-blind, Dose-escalation, Phase...
Analyst ratings
73%
of 22 ratingsBuy
72.7%
Hold
27.3%
Sell
0%
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.